
Address
Molecular Medicine
Department of Medical Sciences
Entrance 70, 3rd floor
Research dept. II
University Hospital
SE-751 85 UPPSALA
- See About us/Personnel for additional contact information

Molecular Medicine
Department of Medical Sciences
Entrance 70, 3rd floor
Research dept. II
University Hospital
SE-751 85 UPPSALA
The research group in Molecular Medicine headed by Professor Ann-Christine Syvänen was started in 1998. Since the start we have been located at the Research Department of Uppsala University Hospital.
Our research group studies human diseases using modern methods for genomics and epigenetics. We develop novel methods for genome analysis, establish these methods at the department, and apply them to medical or biological problems within the group and together with clinical collaborators. Our core technology is “minisequencing” primer extension pioneered by us.
The research group in Molecular Medicine has seventeen members working with research projects in human genetics and technology development. Our research group is a partner in the European research projects: Cardiogenics, ENGAGE, Procardis, Geuvadis and ESGI (European Sequencing and Genotyping Infrastructure). The results of our work have been published as original articles in international journals and we have written review articles, PhD theses and book chapters related to our work.
We co-organize and teach courses in Molecular Medicine and genotyping and sequencing technology targeted at students of different levels.
2012-04-23
Large grant for epigenetic and genomic analyses of the brain from VR, FAS, Formas and Vinnova to Molecular Medicine and the SNP&SEQ platform.
2012-03-16
The SNP&SEQ Technology Platform has installed a MiSeq instrument from Illumina.
2011-12-14
Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.
2011-11-17
VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.
2011-10-04
Molecular Medicine research group has received funding from the K&A Wallenberg foundation.
2011-08-11
A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.
2011-06-20
The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.
2011-03-06
Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.
2011-01-18
The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.